| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/04/2001 | US6284275 Controlled release tablet having a unitary core |
| 09/04/2001 | US6284274 Analgesic tablet compositions |
| 09/04/2001 | US6284273 Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
| 09/04/2001 | US6284272 Pharmaceutical compositions containing an effervescent acid-base couple |
| 09/04/2001 | US6284271 Multiple unit effervescent dosage form |
| 09/04/2001 | US6284270 Means for creating a mass having structural integrity |
| 09/04/2001 | US6284269 Pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284267 Amphiphilic materials and liposome formulations thereof |
| 09/04/2001 | US6284266 Transdermal, heating the skin with an exothermic reaction |
| 09/04/2001 | US6284264 Water soluble film for oral administration with instant wettability |
| 09/04/2001 | US6284263 Buccal drug administration in the treatment of female sexual dysfunction |
| 09/04/2001 | US6284262 Sexual disorders |
| 09/04/2001 | US6284235 Bioadhesive composition |
| 09/04/2001 | US6284234 Topical delivery systems for active agents |
| 09/04/2001 | US6284226 Aerosol composition containing middle-chain fatty acid triglyceride dispersant |
| 09/04/2001 | US6284163 Sol-gel encapsulation of lipid vesicles, lipid membranes and proteins |
| 09/04/2001 | US6283953 Osmotic drug delivery monitoring system and method |
| 09/04/2001 | US6283938 Medicating bandage and controllable permeable membrane |
| 09/04/2001 | CA2138668C Vaginal discharge collection and drug delivery device |
| 09/04/2001 | CA2086120C Topical ophthalmic suspensions |
| 09/04/2001 | CA2056067C A physical form of n-¬4-¬5-(cyclopentyloxcarbony)-amino-1-methylindol-3-yl-methyi|-3-methoxybenzoy1|-2-methyibezenesulphonanide, processes for its preparation and compositions containing it |
| 09/04/2001 | CA2050298C Dry powder inhalation device |
| 09/04/2001 | CA2039491C Stable compositions for parenteral administration and method of making same |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 09/04/2001 | CA2019779C Intermittent release dosage form |
| 08/30/2001 | WO2001063368A2 Compliance tracking method |
| 08/30/2001 | WO2001063191A1 Method for producing particulate goods |
| 08/30/2001 | WO2001062805A1 Cationic polymers and matrices capable of being biologically eliminated with controlled degradation |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062774A2 Purified lh |
| 08/30/2001 | WO2001062760A2 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| 08/30/2001 | WO2001062744A2 Substituted piperazine compounds |
| 08/30/2001 | WO2001062374A2 Method for producing nanosuspensions |
| 08/30/2001 | WO2001062334A2 System and method for preventing sudden cardiac death by nerve sprouting from right stellate ganglion |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062291A1 Compositions for preventing and treating digestive diseases |
| 08/30/2001 | WO2001062290A2 Methods and compositions for improving sleep |
| 08/30/2001 | WO2001062283A2 Mucosal adjuvant formulation |
| 08/30/2001 | WO2001062276A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 08/30/2001 | WO2001062268A1 Endoparasiticidal agents |
| 08/30/2001 | WO2001062267A2 Oral gel containing sulfurated amino acid compounds |
| 08/30/2001 | WO2001062264A2 Halotherapy method by inhalation of sodium chloride |
| 08/30/2001 | WO2001062261A1 Metalloproteinase inhibitors for the treatment of respiratory diseases |
| 08/30/2001 | WO2001062257A2 Bupropion metabolites and methods of their synthesis and use |
| 08/30/2001 | WO2001062256A1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 08/30/2001 | WO2001062254A1 Patches containing buprenorphine hydrochloride |
| 08/30/2001 | WO2001062249A1 Use of pramipexole for the treatment of addictive disorders |
| 08/30/2001 | WO2001062248A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives |
| 08/30/2001 | WO2001062247A1 Topical compositions containing thiazolium compounds and methods of using same |
| 08/30/2001 | WO2001062243A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 08/30/2001 | WO2001062240A2 Use of zwitterion-type detergent for preparing a pharmaceutical composition for nasal delivery |
| 08/30/2001 | WO2001062232A1 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 08/30/2001 | WO2001062231A1 Antibiotic composition with inhibitor |
| 08/30/2001 | WO2001062230A1 Method for producing pharmaceutical dosage forms |
| 08/30/2001 | WO2001062229A1 Therapeutic product, use and formulation thereof |
| 08/30/2001 | WO2001062228A1 Method for transdermal or intradermal delivery of molecules |
| 08/30/2001 | WO2001062227A2 Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease |
| 08/30/2001 | WO2001062226A2 Homogenous solid matrix containing vegetable proteins |
| 08/30/2001 | WO2001062217A2 Oil-based cosmetics containing water-soluble actives |
| 08/30/2001 | WO2001062214A1 Gelled aqueous cosmetic compositions |
| 08/30/2001 | WO2001062195A1 Antibiotic and antifungal compositions |
| 08/30/2001 | WO2001062108A1 Water containing soluble fiber |
| 08/30/2001 | WO2001062086A1 Nutritional intervention composition for enhancing and extending satiety |
| 08/30/2001 | WO2001026705A3 A dual adhesive transdermal drug delivery system |
| 08/30/2001 | WO2001024842A3 Hybrid matrices and hybrid matrix mixtures |
| 08/30/2001 | WO2001013927A3 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 08/30/2001 | WO2001013899A3 Therapeutic system containing an active substance and comprising at least two polymerous layers |
| 08/30/2001 | WO2001010430A3 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 08/30/2001 | WO2001006985A3 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations |
| 08/30/2001 | WO2000074655A3 Delayed total release two pulse gastrointestinal drug delivery system |
| 08/30/2001 | WO2000053164A9 Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| 08/30/2001 | WO2000044682A9 Biodegradable glass compositions and methods for radiation therapy |
| 08/30/2001 | US20010018489 Graft polymer of vinyl ester and polyether |
| 08/30/2001 | US20010018460 Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness |
| 08/30/2001 | US20010018426 Lithium chloride |
| 08/30/2001 | US20010018417 Of sodium lauryl sulfate, a buffering agent to provide acidic pH when the mixture is added to water, and colloidal silica; mixture added to animal feeds |
| 08/30/2001 | US20010018212 Molecular weight of 14,000 to 24,000 daltons; treating infectious diseases and malignant tumors with said protein |
| 08/30/2001 | US20010018098 Method of depositing particles with an electrostatic chuck |
| 08/30/2001 | US20010018082 Effervescent calcium supplements |
| 08/30/2001 | US20010018075 Process for producing sustained-release preparation |
| 08/30/2001 | US20010018074 Admixing carrier particles with a solution of (R-(Z)-alpha-(methoxyimino)-alpha-(1-azabicyclo (2.2.2)oct-e-yl) acetonitrile monohydrochloride in water for treatment of dementia |
| 08/30/2001 | US20010018073 Drug delivery; steroids or hormones penetrate due to combination with destructuring agent and structuring agent in common matrix; useful in treatment of hypogonadism, infertility, or contraception |
| 08/30/2001 | US20010018072 Solid matrix therapeutic compositions |
| 08/30/2001 | US20010018071 Oral 2-methyl-thieno-benzodiazepine formulation |
| 08/30/2001 | US20010018070 Extending the duration of drug release within the stomach during the fed mode |
| 08/30/2001 | US20010018069 Oral administration of fast-dispersing/disintegrating forumulation of dopamine agonist, antiemetic, opioid antagonist, testosterone, and flavored carrier; pregastric absorption; side effect reduction |
| 08/30/2001 | US20010018054 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 08/30/2001 | US20010018053 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/30/2001 | EP1143939A3 Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers |
| 08/30/2001 | CA2657986A1 Substituted piperazine compounds |
| 08/30/2001 | CA2400953A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives |
| 08/30/2001 | CA2400708A1 Methods and compositions for improving sleep |
| 08/30/2001 | CA2400691A1 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| 08/30/2001 | CA2400610A1 Endoparasiticidal compositions comprising a cyclic depsipeptide |
| 08/30/2001 | CA2399418A1 Metalloproteinase inhibitors for the treatment of respiratory diseases |
| 08/30/2001 | CA2399211A1 Foam-forming wound dressing |
| 08/30/2001 | CA2397874A1 Use of pramipexole for the treatment of addictive disorders |
| 08/30/2001 | CA2394088A1 Method for transdermal or intradermal delivery of molecules |
| 08/30/2001 | CA2368665A1 Oil-based cosmetics containing water-soluble actives |